Related references
Note: Only part of the references are listed.FACTORS DETERMINING BONE MINERAL DENSITY LOSS IN CHRONIC HEPATITIS B PATIENTS: IS TENOFOVIR DISOPROXIL FUMARATE THE MAIN CULPRIT?
U. S. Gill et al.
GUT (2011)
HBV DNA replication mediated by cloned patient HBV reverse transcriptase genes from HBV genotypes A-H and its use in antiviral phenotyping assays
Yuao Zhu et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
Gloria Woo et al.
GASTROENTEROLOGY (2010)
Long-Term Efficacy of Tenofovir Monotherapy for Hepatitis B Virus-Monoinfected Patients After Failure of Nucleoside/Nucleotide Analogues
Florian van Boemmel et al.
HEPATOLOGY (2010)
Treatment of children with chronic hepatitis B virus infection in the United States: Patient selection and therapeutic options
Maureen M. Jonas et al.
HEPATOLOGY (2010)
Clinical Outcomes in Adults with Chronic Hepatitis B in Association with Patient and Viral Characteristics: A Systematic Review of Evidence
Brent C. Taylor et al.
HEPATOLOGY (2009)
Hepatitis B Virus DNA Levels and Outcomes in Chronic Hepatitis B
Chien-Jen Chen et al.
HEPATOLOGY (2009)
Recommendations for Screening, Monitoring, and Referral of Pediatric Chronic Hepatitis B
Barbara A. Haber et al.
PEDIATRICS (2009)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hepatitis B e antigen-positive chronic hepatitis B: Natural history and treatment
JJ Feld et al.
SEMINARS IN LIVER DISEASE (2006)
Long-term lamivudine therapy for children with HBeAg-positive chronic hepatitis B
EM Sokal et al.
HEPATOLOGY (2006)
A mathematical model to estimate global hepatitis B disease burden and vaccination impact
ST Goldstein et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2005)
Clinical trial of lamivudine in children with chronic hepatitis B
MM Jonas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
